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Vibrio cholerae, a Gram-negative bacterium found in natural aquatic 
environments, is the causative agent of cholera, a severe diarrheal disease most 
commonly spread through drinking water. An essential component to this pathogen’s 
success and persistence in the environment is its ability to attach to both biotic and 
abiotic surfaces via biofilm formation. Biofilms not only aid in surface attachment, but 
also provide a barrier that protects and enhances survival.  Water-soluble extracts from 
the North American cranberry (Vaccinium macrocarpon) were found to dramatically 
inhibit V. cholerae biofilm formation at a low concentration of 2mg/ml. This inhibition 
was not due to acidification of the growth medium or any bactericidal or bacteriostatic 
effects.  The biofilm inhibition also appeared to be specific to V. cholerae.  Furthermore, 
a decrease in biofilm was also observed when water-soluble cranberry extracts (WSCE) 
were added after four hours of pre-incubation of the culture statically. The vps operons, 
which encode the major component of V. cholerae biofilm, exopolysaccharide, were 
significantly down-regulated in the presence of WSCE by qRT-PCR assays. The vps 
operons are controlled by a set of transcriptional activators and repressors within a 
tangled signaling network and are regulated in a unique cell density dependent manner 
known as quorum sensing. To test whether the master quorum-sensing regulator HapR is 
involved in this cranberry-mediated anti-biofilm effect, the same biofilm inhibition assay 
was conducted in a hapR deletion mutant. A similar level of inhibition was detected, 
suggesting that HapR does not appear to be required for the inhibition by WSCE.  To 
 iii
further confirm this finding, a wild type V. cholerae strain containing a hapR-lacZ fusion 
plasmid was used to determine in vivo expression driven by the hapR promoter and 
measured by β-galactosidase activities.  Additionally, it was determined that the 
intracellular concentration of cyclic diguanylate (c-di-GMP), an important second 
messenger used in signal transduction, is significantly reduced in the presence of WSCE.  
In summary, the results suggest a potential application of WSCE as an alternative and 
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The North American cranberry (Vaccinium macrocarpon), having numerous 
health benefits associated with its consumption, has been well acknowledged by the 
public as a functional food. The bioactive compounds that make up the cranberry have 
been thoroughly analyzed and their biological properties have been well characterized.  
Among the many components that make up this functional food, there is an extremely 
high concentration of total polyphenols including flavonols, flavan-3-ols, 
proanthocyanidins, anthocyanins and phenolic acid derivatives (1-4).  Studies have 
shown that many of these phytochemical compounds have been linked to various health 
benefits (5-8).  It has been long known that cranberries have protective properties against 
urinary tract infections. This effect was first thought to have been caused simply by 
acidification of the urine.  More recent studies have shown that the condensed tannins 
contained within cranberries, specifically proanthocyanidins, hinder bacterial surface 
attachment(9).  Cranberries have also been demonstrated to cause down-regulation of 
genes encoding outer membrane proteins in Escherichia coli O157:H7 (8).  As a result of 
the many antimicrobial properties associated with cranberries, some studies have even 
suggested the use of these bioactive compounds as a means of overcoming issues related 





Vibrio cholerae is a Gram-negative rod shaped bacterium that inhabits a vast 
ecological range of brackish and estuarine waters around the world (10-17).  It is the 
causative agent of a severe diarrheal, and frequently fatal, disease called cholera that 
most commonly occurs in the form of an epidemic (18). With an estimated 3-5 million 
cholera cases resulting in 100,000 – 120,000 deaths every year, as reported in 2014 by the 
World Health Organization, this disease is still endemic in many parts of the developing 
world (19). V. cholerae is capable of surviving and adapting under a vast range of 
environmental conditions.  This has been largely attributed to various adaptive responses, 
including the ability to convert into a viable but non-culturable state during unfavorable 
conditions, as well as its ability to transition between planktonic and biofilm form (20, 
21).  In the planktonic form, V. cholerae is extremely motile, traveling at speeds of up to 
60 cell-body lengths per second (22).  In its biofilm form, V. cholerae acquires an 
increased resistance to many environmental stressors such as desiccation, attack by the 
immune system, protozoa ingestion, and antimicrobials (23).  Biofilms also facilitate in 
the attachment to both biotic and abiotic surfaces (20).  For these reasons, among others, 
biofilm formation is an essential component to this pathogen’s success and persistence in 
the environment.  There are five stages of biofilm development: initial attachment, 
irreversible attachment, maturation I, maturation II, and dispersion (24).  Biofilms not 
only aid in surface attachment and survival in the natural environment, they also provide 
a barrier that protects and enhances survival in human infection.  When V. cholerae 
enters the body, it must first survive the acidic environment of the stomach and then 
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proceed to attach to the intestinal wall.  Therefore, biofilms are also critical for 
transmission and infectivity (25). 
 
Biofilm Regulation in V. cholerae 
 Unlike many other bacteria, a unique density dependent regulation of biofilm 
formation is used in V. cholerae.  Biofilm producing genes, as well as virulence factors, 
are maximally expressed at low cell density and inversely, virulence factors and biofilm 
formation is turned off at high cell density.  This unique system is thought to aid in V. 
cholerae’s life cycle, allowing it to attach and detach from its human host in order to 
transition back to its natural environment (26). 
Biofilms are mainly composed of a substance called exopolysaccharide (EPS), 
which is termed VPS in V. cholerae.  VPS is synthesized by enzymes encoded by the vps 
genes; vpsA-K, in the vpsI operon, and vpsL-Q, in the vpsII operon  (27, 28).  There are 
also numerous matrix proteins encoded in the vps intergenic region, termed rbmA-F 
(rugosity and biofilm structure modulators), responsible for the maintenance of biofilm 
structure and stability (28-30).  The two vps operons are positively regulated by two 
transcriptional regulators, VpsR and VpsT (25), which are regulated through a complex 
set of quorum sensing pathways comprised of at least three sensory systems, two of 
which are well studied (26).  The first sensory system is used for intra-species 
communication and has two key genes, cqsA and cqsS, that are required for the 
biosynthesis and detection of cholera autoinducer-1 (CAI-1), respectively (26, 31-33).  
The second sensory system is used for inter-species communication and has three key 
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genes, luxS and luxP/luxQ, required for the synthesis and detection of autoinducer-2 (AI-
2), respectively (32, 34). The information from these two quorum-sensing systems feed 
into a response regulator called LuxO (26).  LuxO, in association with the alternative 
sigma factor σ54, controls the transcription of genes encoding five small regulatory 
RNAs, Qrr1-5 (35), which regulate the two master quorum-sensing regulators in V. 
cholerae, AphA and HapR (36). These two master regulators control the expression of 
numerous genes involved in virulence and biofilm formation. Studies have also shown 
that hapR expression leads to a decrease in concentration of the nearly ubiquitous second 
messenger molecule, c-di-GMP, which has recently been recognized as a key component 
of V. cholerae’s signaling system  (37). 
In V. cholerae, c-di-GMP regulates several cellular processes including biofilm 
formation and virulence factor production.  The intracellular level of c-di-GMP is 
regulated by proteins containing GGDEF and/or EAL domains, which function as 
diguanylate cyclases (DGC’s) and phosphodiesterases (PDE’s), respectfully (37-44).  
Studies have shown that high levels of c-di-GMP can strongly induce biofilm production 
by directly binding with the transcriptional regulator VpsR, which then activates vpsT 
and aphA transcription (43).  Together, c-di-GMP and the quorum-sensing pathway are 
two important regulatory systems that collectively control the activation and repression of 






In the current study, we seek to understand the molecular mechanisms of this 
cranberry-mediated inhibition of V. cholerae biofilm.  It was found that when static 
cultures of V. cholerae were exposed to WSCE, at a concentration of 2mg/ml, biofilm 
formation was significantly inhibited.  This inhibition was not due to acidification of the 
growth medium or any bactericidal or bacteriostatic effects.  The biofilm inhibition also 
appears to be specific to V. cholerae.  A decrease in biofilm formation was also observed 
when WSCE was added to a pre-established static culture of V. cholerae.  Four key genes 
in the quorum-sensing pathway (cqsA, luxS, luxO and hapR) were then tested and shown 
to be uninvolved in the WSCE-mediated biofilm inhibition.  Furthermore, qRT-PCR 
assays reveal that both of the vps operons were significantly down-regulated in the 
presence of WSCE.  Interestingly, vpsR, which encodes the transcriptional activator for 
vpsI and, indirectly, vpsII is not down-regulated.  Additionally, it was determined that the 
intracellular concentration of an important second messenger used in signal transduction, 
cyclic diguanylate (c-di-GMP), is significantly reduced in the presence of WSCE.  It is of 
particular relevance that c-di-GMP is required as a cofactor for the proper function of 
VpsR.  Moreover, this study has the potential to provide an alternative means of V. 




MATERIALS AND METHODS 
 
Bacterial Strains and Media 
The bacterial strains used in this study are listed in Table 2.1.  The V. cholerae, 
Pseudomonas aeruginosa, Salmonella typhimurium and Escherichia coli strains were 
cultured in Luria-Bertani (LB) medium.  The Staphylococcus aureus, Enterococcus 
faecalis and Listeria monocytogenese strains were cultured in brain-heart infusion (BHI) 
medium.  When performing inoculations for overnight cultures, streptomycin (100µg/ml) 
was used for antibiotic selection of all V. cholerae C6706 strains.  Streptomycin 
(100µg/ml) and tetracycline (1µg/ml) was used for antibiotic selection of all V. cholerae 
C6706 strains carrying the pBB1 plasmid.  When using strains carrying the pBB1 
plasmid for luminescence assays cultures were always maintained at 25°C or 30°C.  All 








































































































































































































































































































































































































































































































































































































































Preparation of Water-Soluble Cranberry Extracts 
 The cranberry extract (CBE) used in this study was received from DECAS 
Cranberry Products, Inc. and referred to as HI-PAC BL DMAC 5.  Lab stocks of CBE 
were received in lyophilized form and stored at -80°C.  Working solutions of CBE were 
prepared as needed by dissolving the CBE power in water at a 5% concentration (w/v).  
The solution was then centrifuged at 16,000 x RPM for 5 minutes in order to remove all 
non-water-soluble components.  The supernatant, containing only WSCE, was then 
collected and used for treatments at the desired concentration. 
 
Isolation of Planktonic Cells 
 Many experiments in this study focused on observing the cells transition phase, 
i.e., when the transformation from planktonic form to biofilm form was induced.  This 
required the collection of only planktonic cells from samples, in which a mature biofilm 
had been formed, while collecting as few biofilm cells as possible.  The planktonic cells 
were isolated from biofilm cells by first gently vortexing the test tube in order to detach 
the biofilm pellicle from the test tube wall.  Next, the test tube was angled at 
approximately 45 degrees and rotated so that the biofilm pellicle would attach completely 
to the side of the test tube wall.  Once this was done, the test tube was angled up right, 
leaving the planktonic cells exposed and the biofilm pellicle remaining attached to the 




Crystal Violet Assay 
Crystal violet assays were used as an initial means of quantifying biofilm and 
measuring the inhibition that was caused by WSCE treatment.  It served as a quick and 
simple screening technique to measure biofilm inhibition as a result of various WSCE 
treatment concentrations.  The crystal violet assay was later replaced with the standard 
plate count method to more accurately quantify biofilm formation as CFUs/ml.  The 
crystal violet assays were conducted using both 96-well plates and polystyrene test tubes. 
1:100 dilutions of overnight cultures were inoculated into 1ml of LB in polystyrene test 




.  Each culture was treated with 
WSCE at concentrations of 0mg/ml (control) and 2mg/ml.  Biofilms were allowed to 
form by incubating the cultures at 25°C for 24 hours under static conditions.  Stains were 
observed, photographed, dissolved in DMSO, and quantified at OD570. 
 
Biofilm Inhibition Assay 
Overnight cultures of V. cholerae were inoculated into 1ml of LB in polystyrene 















.  Each culture was treated with WSCE at concentrations of 
0mg/ml (control) and 2mg/ml.  Biofilms were allowed to form by incubating the cultures 
at 25°C for 24 hours under static conditions.  First, samples of planktonic cells were 
plated onto LB agar plates at appropriate dilutions.  Then, the planktonic cells were 
removed, biofilms were washed with 1X PBS, and resuspended in 1ml of ddH2O.  
Before biofilm samples were plated onto LB agar, 3-5 1mm glass beads were added to 
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each sample and agitated for two minutes using a vortex to disrupt the biofilm pellicle.  
LB agar plates containing both planktonic and biofilm samples were incubated at 37°C 
overnight, colonies were counted and CFU’s were calculated.  Experiments were 
conducted in triplicates.  P-value’s were determined by Student’s t test. 
 
Growth Curve 
Cultures were grown overnight for 10 hours at 30°C and rotary shaking at 150 
RPM.  Samples were then diluted so that each culture had an equal cell density 
(approximately 1:1000).  WSCE was added at a concentration of 2mg/ml.  50mL of 
diluted culture was incubated at 25°C under static conditions for 24 hours.  Samples were 
plated hourly and quantified using the standard plate count method. 
 
Pre-established Biofilm Inhibition Assay 
Overnight cultures of V. cholerae were inoculated into 1ml of LB in polystyrene 
test tubes (1:100 dilution).  Cultures were incubated under static conditions at 25°C for 4 
hours in order to allow the cultures to reach phase I of biofilm establishment.  After 4 
hours samples were treated with WSCE, at a concentration of 2mg/ml, and reincubated at 
25°C under static conditions for the remaining 20 hours.  First, samples of planktonic 
cells were plated onto LB agar plates at appropriate dilutions.  Then, the planktonic cells 
were removed, biofilms were washed with 1X PBS, and resuspended in 1ml of ddH2O.  
Before biofilm samples were plated onto LB agar, 3-5 1mm glass beads were added to 
each sample and agitated for two minutes using a vortex to disrupt the biofilm pellicle.  
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LB agar plates containing both planktonic and biofilm samples were incubated at 37°C 
overnight, colonies were counted and CFU’s were calculated.  Experiments were 
conducted in triplicates. P-values were determined by Student’s t test. 
 
Motility Assay 
Overnight cultures of V. cholerae were inoculated into 1ml of LB in polystyrene 
test tubes (1:100 dilution). Cultures were incubated with rotary shaking at 150rpm at 
37°C for 5 hours and then 2µl samples of each strain were dropped onto motility plates 
containing 0.3% agar.  Plates were incubated in the dark at room temperature for 12 
hours and then photographed and observed for motility. 
 
Hydrophobicity Assay 
 Overnight cultures of V. cholerae were inoculated into 1ml of LB in glass test 
tubes (1:100 dilution) in replicates of three.  Cultures were grown at 25°C and rotary 
shaking at 150 RPM for 24 hours.  Samples were then transferred to 1.5ml eppendorf 
tubes and washed twice with 0.85% NaCl at 8,000 x g for 2 minutes.  Samples were then 
transferred to glass test tubes and resuspended in 3ml of 0.85% NaCl.  Spectrophotometer 
readings were then measured for each sample at 600nm and recorded as the OD Initial.  
Next, 0.25ml of toluene was added to each sample and vortexed for 2 minutes.  Samples 
were then permitted to equilibrate for 30 minutes, allowing the toluene phase to separate 
from the aqueous phase.  Spectrophotometer readings were then measured from the 
aqueous phase of each sample at 600nm and recorded as the OD Final.  The 
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Hydrophobicity Index (HPBI) was then calculated using the following formula: (OD 
Initial - OD Final)/OD Initial*100%=HPBI.  Experiments were conducted in triplicates. 
P-values were determined by Student’s t test. 
 
Luminescence Assay 
Cultures were grown overnight for 10 hours at 30°C and 150 RMP.  Samples 
were then diluted so that each culture had an equal cell density (approximately 1:1000).  
WSCE was added at a concentration of 2mg/ml.  50mL of diluted culture was incubated 
at 25°C under static conditions for 24 hours.  Every hour samples collected and 
luminescence was measured using a BioTek® Synergy H1
TM




Overnight cultures of V. cholerae were inoculated into 1ml of LB in polystyrene 
test tubes (1:100 dilution) in triplicate.  Cultures were grown at 25°C, under static 
conditions, and samples were collected at 4h, 8h, 16h and 24h time-points, representing 
key phases of growth based on our growth curve.  In order to observe the expression of 
hapR during the cells transition phase, which would induce the transformation of a cell 
from planktonic form to biofilm form, only planktonic cells were collected from the 
samples. Samples were lysed and ortho-Nitrophenyl-β-galactosidase (ONPG) was used to 
measure the level of beta-galactosidase within the cell. Experiments were conducted in 
triplicates. P-values were determined by Student’s t test. 
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Quantitative Real Time-PCR 
Overnight cultures of V. cholerae were inoculated into 1ml of LB in polystyrene test 
tubes (1:100 dilution) in triplicate.  Cultures were grown at 25°C, under static conditions.  
Samples were collected at 4h and 24h time-points, representing early and late stages of 
biofilm development.  In order to observe the gene expression during the cells transition 
phase, which would induce the transformation of a cell from planktonic form to biofilm 
form, only planktonic cells were collected from the samples.  All RNA samples were 
prepared using RNAzol RT reagent (Molecular Research Center, INC.) and stored at -
80°C.  Complementary DNA was synthesized using the BioRad iScriptTM cDNA 
synthesis kit.  qPCR was performed using SensiFAST SYBR No-Rox Kit (Bioline) and 
the CFX96 real-time PCR detection system according to the manufacturer’s suggested 
protocol (Bio-Rad). The qPCR conditions were: 95°C for 3 minutes, followed by 40 
cycles of 5 s at 95°C, 10 s at 50°C and 15 s at 72°C.  Relative fold-changes for transcripts 
were calculated using the comparative CT (2-∆∆CT) method. Cycle thresholds of 
amplification were determined by Light Cycler software (Bio-Rad). Each qRT-PCR 
experiment was repeated three times using independent RNA preparations. The data were 
pooled and analyzed using unpaired Student’s t-test, and p<0.05 was accepted as 
statistically significant. The qPCR primers used in this study are listed in Table 2.2.
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Table 2.2 Oligos used in this study       
Name    Sequence        
16S rRNA-F   5'-GGA AAC GAT GGC TAA TAC CG-3' 
16S rRNA-R   5'-GCC CTT ACC TCA CCA ACT AG-3' 
luxO-F    5'-GCG AAA GTG GTA CAG GTA AAG-3' 
luxO-R   5'-CCC TTT GAC GTG ACC AAA C-3' 
hapR-F   5'-CGA TTG TCA CTG GCT CAA AG-3' 
hapR-R   5'-GCA GTT GGT TAG TTC GGT TG-3' 
vpsR-F   5'-GGC CAT GTA TTG GTA TTG TGG-3' 
vpsR-R   5'-GGC AAA TGG TAT CTG AAC TGA G-3' 
vpsT-F    5'-GTC CGC AGG ATA TTG AGC AT-3' 
vpsT-R   5'-GCC TTT GAT CAG GGT ATC CA-3' 
vpsD-F   5'-CAT CCA AGA GCA ACT GAA AG-3' 
vpsD-R   5'-GCA AGG TCA ACA CAT TAC GAG-3' 
vpsL-F    5'-TTC TTT ACA TAC GGC ATT C-3' 
vpsL-R   5'-GCC AAT AAA AGA ACC GAC-3' 
epsE-F    5'-CTA ACC CAA GTC TAT CAG-3' 
epsE-R   5'-AAT CTT CGT TTT GAG GC-3' 
mshA-F   5'-CAT TGC CCA TAA GTT TG-3' 
mshA-R   5'-GTT CCT GTA GAC GAT TG-3' 
cdgA-F   5'-GTT TAC TGA GAT GCT GG-3' 
cdgA-R   5'-GCT CAT ATT TCA CCA TCA C-3' 
cdgB-F   5'-GCC AAT CCT GAA ATT CTG-3' 
cdgB-R   5'-AAC CGA CCA GAT AAG AG-3' 
cdgC-F   5'-TTC TCA ACC GAC TAC AC-3' 
cdgC-R   5'-CGA TCT GCT CCA TAA AAC-3' 
cdgD-F   5'-GGA TAG ACA AGG AAA AGA AC-3' 
cdgD-R   5'-GTC GTT TGA GCA GAT TC-3' 
rmbA-F   5'-TGG GTT CCA GAG TAT ATG-3' 
rmbA-R   5'-GAG TTC AGG TAG GCT ATT-3' 
rmbB-F   5'-CAG CAG GAA CAG AAA TG-3' 
rmbB-R   5'-CCT TAG CTC CTC TAG TAT C-3' 
rmbC-F   5'-CGA AGCA ATA AGA AAG TGG-3' 
rmbC-R   5'-GCC TTC AAC TAA CCA AC-3' 
bap1-F    5'-CGC TGG CAC ACT AAA CAA G-3' 
bap1-R   5'-CCA TAC ATT CAT ACC CAA GAG C-3' 
flaA-F    5'-GGA TTA AAG ATA CGG ATT TTG-3' 
flaA-R    5'-CGA GAT TGC AGA GTT TG-3' 
pomB-F   5'-CTC TTG CTC TCG TTT TC-3' 




Recently, a group of chemists devised a way to quantify c-di-GMP concentration 
using a fluorescent dye called Thiazole Orange (TO).  They found that c-di-GMP can 
exist in different aggregate forms when monovalent cations are present in solution (1M 
NaCl).  TO can then form complexes with these aggregates and can be detected by 
fluorescence using excitation and emission wavelengths of 508nm and 557nm, 
respectively (48). Using this method, c-di-GMP levels were quantified in samples of V. 
cholerae that were treated with WSCE and compared to control samples.  Overnight 
cultures were inoculated into 1ml of LB in polystyrene test tubes (1:100 dilution) in 
quintuplicate.  Cultures were grown at 25°C, under static conditions, and samples were 
collected at 4h, 8h, 16h and 24h time-points, representing key phases of growth based on 
our growth curve.  In order to observe the change in c-di-GMP concentration during the 
cells transitional phase, which would induce the transformation of a cell from planktonic 
form to biofilm form, only planktonic cells were collected from samples.  During 
collection, five 1ml samples were concentrated into a single 0.8ml sample, by 6.25x.  
Cells were then lysed by sonication at 30W for 60 seconds (three 20 second pulses), 
trichloroacetic acid (TCA) was used to precipitate cellular macromolecules and 
centrifugation was used to separate the precipitate.  The remaining cell lysate, containing 
only small molecules, was collected and filtered through a 0.2µm filter.  A sample of the 
cell lysate was then diluted 1:10 into a buffer (10mM Tris-HCL (pH 8.0) containing 1M 
NaCl), incubated at 95°C for 5 minutes, and cooled to room temperature.  TO was then 
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added to each sample at a working concentration of 30µM and incubated at 4°C for 12h 
and fluorescence readings were then taken.  The concentration of c-di-GMP was 
calculated using a calibration curve. Experiments were conducted in triplicates. P-values 






WSCE At Very Low Concentration (2mg/ml) Inhibit 
 Biofilm Formation Without Affecting Bacterial Growth 
The formation and inhibition of biofilm was first observed in a test tube as a 
significant reduction in pellicle size, shown in Figure 3.1-A.  The inhibition was then 
measured, both qualitatively and quantitatively, using a test tube crystal violet assay and 
the standard plate count method, shown in Figures 3.1-B, C and D.  When wild-type V. 
cholerae is treated with WSCE the production of biofilm is significantly reduced in a 
density dependent manner, shown in Figure 3.1-C.  Our results, shown in Figure 3.1-D, 
indicated that when wild-type V. cholerae was treated with WSCE at concentrations 
greater than 3mg/ml cell viability began to decrease significantly in a density dependent 
manner.  When conducted in parallel, these two studies revealed that WSCE, at a very 
low concentration (2mg/ml), inhibited biofilm formation without affecting bacterial 
growth.  To further confirm that WSCE treatment did not affect bacterial growth, a 24-




Figure 3.1.  Effect of WSCE on biofilm formation and cell viability. (A) Biofilm pellicles 
formed by V. cholerae C6706 in the absence and presence of WSCE. (B) Crystal violet 





Figure 3.1. Effect of WSCE on biofilm formation and cell viability. (C) Crystal violet 
staining results of V. cholerae C6706 biofilm in the presence of various concentrations of 
WSCE. (D) Twenty-four-hour static growth of V. cholerae C6706 in the presence of 




Figure 3.1. Effect of WSCE on biofilm formation and cell viability. (E) Twenty-four-
hour growth curve of V. cholerae C6706 in the presence and absence of WSCE at a final 
concentration of 2mg/ml. 
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WSCE-Mediated Biofilm Inhibition Is Specific To Vibrio cholerae 
Biofilm formation was compared among eight different bacterial species treated 
with WSCE in order to determine the effects on various bacterial pathogens.  Cells in 
both planktonic form and biofilm form were isolated, quantified separately using the 
standard plate count method, and then compared.  The results shown in Figure 3.2 reveal 




Figure 3.2. Quantification of biofilm formation in V. cholerae C6706 and seven other 
bacterial species in the absence and presence of WSCE. ** indicates p < 0.001.
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WSCE Treatment Does Not Affect Motility or Initial Surface Attachment 
A motility assay was conducted on V. cholerae in the absence and presence of 
WSCE.  The results shown in Figure3.3-A indicate that the motility of V. cholerae is not 
affected by WSCE. Next, these results were confirmed by testing the gene expression of 
an important flagellar structural gene, flaA, and an important flagellar motor gene, pomB, 
using qRT-PCR.  Figure 3.3-B shows no significant decrease in gene expression of either 
flaA or pomB in the presence of WSCE.  A pre-established biofilm inhibition assay was 
then conducted in order to determine the effect of WSCE on initial surface attachment.  
The results shown in Figure 3.3-C indicate that WSCE treatment can inhibit and reverse 
the maturation of a pre-established biofilm, suggesting that WSCE does not affect initial 
surface attachment.  Lastly, these results were confirmed by testing the gene expression 
of mshA, using qRT-PCR.  As shown in Figure 3.3D, the gene expression of mshA does 




Figure 3.3.  (A) Motility assay on 0.3% soft agar plate. (B) Quantitative real-time PCR 





Figure 3.3. (C) Bacterial cultures were allowed to pre-establish for 4 hours before treated 
with WSCE.  (D) Quantitative real-time PCR analysis of type IV pilus attachment gene, 
mshA. * indicates p < 0.05.
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WSCE Mainly Affects The Development Phase of Biofilm Formation 
Studies have shown that reducing the CSH of bacterial cells would be an effective 
method for inhibiting biofilm formation (49, 50).  A reduction in CSH can be interpreted 
as a reduction in EPS production (51).  Using a hydrophobicity assay, the CSH was 
calculated and compared between WSCE-treated and non-treated cultures of V. cholerae.  
CSH was significantly reduced in cultures grown in the presence of WSCE after 24 
hours, indicating that WSCE causes a decrease in EPS production.  Using qRT-PCR, the 
expression level of various genes encoding proteins responsible for the regulation and 
synthesis of biofilm were quantified and compared between WSCE-treated and non-
treated cultures of V. cholerae.  Genes within the vpsI and vpsII operons, vpsD and vpsL 
respectively, were down-regulated in the presence of WSCE.  Genes encoding biofilm 
matrix proteins bap1, rmbA, rmbB and rmbC were also down-regulated.  As would be 
expected, vpsT, the transcriptional activator for the vpsII operon was down-regulated.  
However, the transcriptional activator for vpsT and the vpsI operon, vpsR, was not down-
regulated.  cdgB, cdgC and cdgE, three genes encoding diguanylate cyclases (DGC’s), 
proteins responsible for the synthesis of c-di-GMP, were down-regulated.  Results were 




Figure 3.4 WSCE affects the development phase of biofilm formation. (A) CSH is 
significantly reduced in cultures grown in the presence of WSCE.  Samples were 





Figure 3.4 WSCE affects the development phase of biofilm formation. (B) qRT-PCR 






Figure 3.4 WSCE affects the development phase of biofilm formation. (C) qRT-PCR 
analyses of some V. cholerae biofilm-related genes. Samples were collected after 24-
hours. * indicates p < 0.05, and ** indicates p < 0.001. 
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WSCE-Mediated Biofilm Inhibition Occurs Independent of hapR 















; four key genes within 
the quorum-sensing pathway (cqsA, luxS, luxO and hapR) were tested for their 
involvement by conducting biofilm inhibition assays.  If biofilm formation were restored 
in any of the mutant strains while exposed to WSCE, the gene that was mutated would be 
presumed to be involved in the WSCE-mediated biofilm inhibition.  Figure 3.5-A shows 
that none of the key genes tested are involved in the WSCE-mediated biofilm inhibition. 
Considering the importance that is placed on HapR in the regulation of biofilm 
formation in V. cholerae, two assays were conducted to test the expression level of hapR 
in WSCE treated cultures.  The first assay utilizes a strain of V. cholerae containing a 
hapR-lacZ transcriptional fusion.  The second method is a luminescence assay. This assay 
utilizes a strain of V. cholerae that contains a plasmid harboring the luminescence 
operon, which is positively regulated by HapR.  An increase or decrease in luminescence, 
relative to the control, will correlate with an increase or decrease in the expression of 
hapR.  To ensure that the WSCE was not interfering with the luminescence detection, a 
strain of V. cholerae that constitutively expresses luminescence was run in parallel.  
Results in Figure 3.5-B showed that hapR expression was significantly reduced in 




Figure 3.5.  WSCE-Mediated Biofilm Inhibition Occurs Independent of hapR. (A) 





















Figure 3.5. WSCE-Mediated Biofilm Inhibition Occurs Independent of hapR. (B) In vivo 
expression driven by the hapR promoter in V. cholerae wt strain as measured by β-




Figure 3.5. WSCE-Mediated Biofilm Inhibition Occurs Independent of hapR. (C) 24-
hour expression of hapR measured by luminescence.
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WSCE treatment reduces the intracellular concentration of c-di-GMP 
Using thiazole orange, c-di-GMP levels were quantified in samples of V. cholerae 
that were treated with WSCE and compared to control samples at 4h, 8h, 16h and 24h.  
Figure 3.6-A shows that the intracellular concentration of c-di-GMP was significantly 





Figure 3.6. WSCE treatment reduces the intracellular concentration of c-di-GMP (A) 
Quantification of intracellular [c-di-GMP] in V. cholerae C6706 in the absence and 
presence of WSCE, K=100,000,000. (B) Calibration curve (equation for trendline: y = 
5.2415x
2
 - 37.046x - 695.83). ** indicates p < 0.001 
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WSCE causes down-regulation of numerous genes required for virulence expression 
Using qRT-PCR, the expression level of numerous genes encoding proteins 
responsible for the regulation and synthesis of virulence factors were quantified and 
compared between WSCE-treated and non-treated cultures of V. cholerae C6706.  Figure 
3.7 shows numerous genes required for virulence factor expression were down-regulated 
in the presence of WSCE. 
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Figure 3.7. qRT-PCR analyses of some V. cholerae virulence-related genes. * indicates p 






Cholera and Treatment 
V. cholerae is the causative agent of cholera, and is most commonly spread 
through inadequate drinking water and leads to severe dehydration and death in some 
cases.  With over 3 million cases of cholera reported worldwide each year, this disease is 
still endemic in many parts of the developing world.  Current treatment methods for 
cholera infection involve rehydration and antibiotic supplementation.  As antibiotic use is 
becoming increasingly ineffective, due to the selective pressure it places on resistant 
strains of bacteria, the need to develop alternative treatment methods is becoming 
extremely important. This study provided data that supports the continued investigation 
for the use of WSCE as an alternative means of V. cholerae biofilm control as well as an 
alternative method of treatment for cholera.  For WSCE to be used as a treatment for 
cholera, ideally more analytical work should be conducted in an attempt to narrow the list 
of active components.  Alternatively, the WSCE powder could be used as a supplement in 
addition to salt hydration packets.  Implementing this type of treatment would be both 
convenient and economical, considering hydration packets are already a major treatment 
method for cholera patients.  In addition to a potential application for treatment, this 
study also provides added insight into the complexity of the quorum sensing system, and 
the role of c-di-GMP as an important second messenger in biofilm and virulence 
regulation. 
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C-di-GMP and Biofilm Formation 
Recent studies from our lab revealed that V. macrocarpon could protect against V. 
cholerae infection in the nematode model system, Caenorhabditis elegans  (52).  In the 
present study, the effects of WSCE on V. cholerae biofilm formation were investigated.  
The production and excretion of exopolysaccharide and biofilm matrix proteins plays an 
essential role in the survival, transmission and infection of this pathogen.  The 
exopolysaccharide used for biofilm formation is synthesized by enzymes encoded by the 
vps genes; vpsA-K, in the vpsI operon, and vpsL-Q, in the vpsII operon  (27, 28).  In this 
study, vpsD was used to represent the expression of the vpsI operon, and vpsL was used 
to represent the expression of the vpsII operon.  The biofilm matrix proteins are encoded 
by genes in the vps intergenic region, termed rbmA-F, responsible for the maintenance of 
biofilm structure and stability (28-30).  In this study, rmbA, rmbB, rmbC and bap1 are 
used to measure the expression of biofilm matrix proteins.  Bap1 is a matrix protein that 
facilitates the adherence of the developing biofilm to surfaces (29).  Another important 
regulator of biofilm formation is c-di-GMP (37-41, 53).  Three genes encoding DGC’s, 
cdgB, cdgC and cdgE, have been shown to regulate expression of genes required for V. 
cholerae polysaccharide synthesis and of the transcriptional regulator genes vpsR, vpsT 
and hapR (41, 44).  Studies have shown that high levels of c-di-GMP can strongly induce 
biofilm production by directly binding with the transcriptional regulator VpsR, which 
then activates vpsT and aphA transcription (43).  The two vps operons, vpsI and vpsII, are 
positively regulated by two transcriptional regulators, VpsR and VpsT, respectively (25).  
Results from this study, shown in Figure 3.4, indicate that the transcriptional activator 
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protein VpsR is being produced in the presence of WSCE.  However, considering that c-
di-GMP is required as a cofactor for the proper function of VpsR, the transcriptional 
activator protein is not able to activate vpsT (and indirectly the vpsII operon) or the vpsI 
operon, ultimately restricting the pathway and drastically reducing biofilm production 
(43).  Moreover, the results from this study show that a significant reduction in biofilm 
formation can be attributed to a decrease in the intracellular [c-di-GMP], leading to an 
overall decrease in the expression of genes within the vpsI and vpsII operons (Figure 3.4 
and 3.6).  A model of the complex regulation of biofilm production by c-di-GMP is 
shown in Appendix A. 
 
Cell Surface Attachment 
There are five stages of biofilm formation: initial attachment, irreversible 
attachment, maturation I, maturation II, and dispersion (24, 54).  The model for biofilm 
formation is shown in Appendix B.  These five stages can be further simplified into two 
potential phases that WSCE could be affecting: the attachment phase and the 
development phase.  During the first phase of attachment the cell is highly dependent 
upon motility, which requires the expression of two important genes: flaA, which encodes 
a flagellum structural protein, and pomB, which encodes a flagellum motor protein (55).  
Once the cell reaches close proximity to a surface, the cell requires expression of mshA, 
which encodes the pilin protein for a mannose sensitive hemaglutinin type IV pilus that is 
essential during initial attachment to abiotic surfaces (ie. test tube) (20). Taken together, 
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the results from this study shown in Figure 3.3 suggest that WSCE does not appear to be 
affecting the attachment phase of biofilm formation. 
 
The Quorum-Sensing System 
The quorum-sensing pathway has been well established in published literature as 
being one of the major pathways responsible for biofilm regulation in V. cholerae (25, 
26, 31-33, 37, 43, 56-64).  In recent literature, the protein HapR has been termed the 
master regulator of the quorum-sensing regulatory system in V. cholerae, and a hapR
-
 
mutant has been shown to have an increased biofilm-forming capacity (26, 53, 63, 65).  
Based on previous studies showing that an increase in hapR expression causes a decrease 
in biofilm formation, we would expect to find an increase in hapR expression linked to 
the biofilm inhibition observed in our WSCE treated cultures (26).  Interestingly, the 
results from Figure 3.5 show a decrease in hapR expression, indicating that WSCE-
mediated biofilm inhibition occurs independent of the master-quorum sensing regulator 
HapR and its upstream regulator LuxO.  These findings not only expand upon the current 
understanding of biofilm regulation in V. cholerae, they place emphasis on its complexity 
and the potential involvement of other regulatory mechanisms.  A model of the complex 
regulation of biofilm production by quorum-sensing is shown in Appendix A. 
 
Future Directions 
Results from this study also indicate that the expression of numerous genes 
involved in the regulation and production of virulence factors are significantly reduced in 
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the presence of WSCE (Figure 3.7).  The two key factors essential for virulence during 
infection are the toxin-coregulated pilus (TCP) and cholera toxin (CT) (66, 67).  The TCP 
is a type IV pilus that is required for colonizing the small intestine, and CT is an 
enterotoxin responsible for inducing cholera symptoms (66, 67).  The transcriptional 
regulator, ToxT, positively regulates the expression of these two virulence factors (68).  
A model of the complex regulation of virulence factor expression by quorum-sensing and 
c-di-GMP is shown in Appendix A. 
In order to expand upon the potential inhibitory effects WSCE has on V. cholerae 
virulence expression, further in vitro infection assays should be conducted using cell lines 
HT-29, HEP-G2 and CHO-K1. Before conducting infection assays, however, an MTT 
assay should be conducted to determine the in vitro growth inhibition effect, if any, of 
WSCE on each of the cell lines using a range of concentrations ranging slightly above 
and below 2mg/ml.  When conducting the infection assays, each of the cell lines should 
be maintained until confluence, washed with 1X PBS and then resuspended in their 
respective medium (69).  Cultures should be infected with V. cholerae at a multiplicity of 
infection (MOI) of ~100, with and without WSCE, and then a proliferation assay should 
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